BRKRP
BRUKER CORPPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 6 Bruker reported Q1 2026 revenue of $823.4M (+2.7% YoY, but -4.4% org…
- X Aug 14 Short interest jumps 588.8% to 5.4K
- X Aug 31 Short interest falls 41.1% to 3.2K
- X Sep 30 Short interest jumps 68.8% to 4.4K
- X Oct 15 Short interest falls 91.2% to 384
Signal stack
Where each data set points today.
- Short sellersCOVERING
Short interest −91.2% to 384 shares. 1.0 days to cover, ≈0.0% of shares.
- TrendRANGE
3% above its 50-day average.
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
5 filings · 0 bullish · 1 bearish · 4 neutral- NEUTRAL 8-KMay 15, 2026
Bruker Corporation declared a quarterly cash dividend of $0.05 per share on its common stock…
No material read-through for BRKRP holders. The common dividend declaration is routine and does not affect the preferred dividend rate or issuer credit profile. Monitor next quarterly earnings for…
- BEARISH 8-KMay 6, 2026
Bruker reported Q1 2026 revenue of $823.4M (+2.7% YoY, but -4.4% organically) and GAAP diluted EPS…
The organic revenue decline and sharp EPS drop confirm ongoing headwinds from academic funding, tariffs, and currency. The reconfirmed FY guidance provides a floor, but Q1 results fell short of the…
- NEUTRAL 8-KApr 28, 2026
Bruker Corporation declared a quarterly cash dividend of $3.9844 per share on its 6.375% Mandatory…
No material trading implications. The preferred dividend is in line with the fixed rate. Monitor for any changes in the common stock dividend policy in future filings.
- NEUTRAL DEFA14AApr 10, 2026
Bruker Corporation filed a definitive proxy statement (DEFA14A) for its 2023 annual meeting, which…
Monitor for potential strategic shifts following board changes, particularly with new director Bernard's background in diagnostics and QIAGEN. The timing of this appointment shortly after an…
All BRKRP filing & press-release reports (5)
- 8-K reportMay 15, 2026
- 8-K reportMay 6, 2026
- 8-K reportApr 28, 2026
- DEFA14A reportApr 10, 2026
- 8-K reportApr 10, 2026